(Q51871886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Ana M Sartori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marcos Amaku

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hillegonda Novaes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

J Valentim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

P C de Soárez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

30 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

6281-6291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18674582%20AND%20SRC:MED&resulttype=core&format=json

Preventing varicella-zoster disease

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella vaccine effectiveness in the US vaccination program: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The safety profile of varicella vaccine: a 10-year review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The impact of varicella vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Impact of varicella vaccination on health care utilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella among adults: data from an active surveillance project, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Effects of varicella vaccination on herpes zoster incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Three year seroepidemiological study of varicella-zoster virus in São Paulo, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella transmission in two samples of children with different social behaviour in the State of São Paulo, Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Childhood vaccination against chickenpox: an analysis of benefits and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Costs And Benefits Of Routine Varicella Vaccination In German Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

A cost benefit analysis of routine varicella vaccination in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Cost–benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The cost-effectiveness of routine childhood varicella vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

[Cost-effectiveness of varicella vaccination in Spanish adolescents]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella vaccination in Italy : an economic evaluation of different scenarios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Cost containment analysis of childhood vaccination against varicella in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The economic value of childhood varicella vaccination in France and Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Economic evaluation of varicella vaccination in Spain: results from a dynamic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

An economic analysis of the universal varicella vaccination program in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

The cost-effectiveness of varicella vaccination in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella vaccination in England and Wales: cost-utility analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella zoster in children attending day care centers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Modelling the impact of immunization on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Primary vaccine failure after 1 dose of varicella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Loss of vaccine-induced immunity to varicella over time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Metaanalysis of vaccine effectiveness in varicella outbreaks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella vaccination in Japan, South Korea, and Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella vaccination in Australia and New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Vaccination against rubella: analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021

Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.021